Calcilytic compounds

   
   

The present invention features calcilytic compounds. "Calcilytic compounds" refer to compounds able to inhibit calcium receptor activity. Also described are the use of calcilytic compounds to inhibit calcium receptor activity and/or achieve a beneficial effect in a patient; and techniques which can be used to obtain additional calcilytic compounds.

 
Web www.patentalert.com

< Pyrimidine carboxamides useful as inhibitors of PDE4 isozymes

< Therapeutic use of the SMR1 protein and active derivatives thereof

> Polyubiquitin based hydrogel and uses thereof

> Single nucleotide polymorphisms in genes

~ 00144